-
Product Name
Anti-IFNA1 antibody
- Documents
-
Description
Rabbit Polyclonal to Human IFNA1
-
Tested applications
WB
-
Species reactivity
Human IFN-alpha / IFNA1 / IFN
-
Alternative names
Ifa1 antibody; IFL antibody; IFN antibody; IFNA@ antibody; IFN-ALPHA antibody; IFN-alpha 1b antibody; IFN-alpha-1 antibody; IFN-alpha-1/13 antibody; IFN-alphaD antibody; interferon alpha 1b antibody; interferon alpha family gene 1 antibody; interferon alpha-1 antibody; interferon alpha-1/13 antibody; interferon alpha-D antibody; interferon-alpha1 antibody; leIF D antibody; MGC138207 antibody; MGC138505 antibody; MGC138507 antibody; RP23-360M23.1 antibody; IFNA13 antibody; IFL antibody; IFN antibody; IFNA@ antibody; IFNA13 antibody; IFN-ALPHA antibody; IFN-alphaD antibody; Ifa1 antibody
-
Isotype
Rabbit IgG
-
Preparation
Produced in rabbits immunized with a synthetic peptide corresponding to the N-terminus of the Human IFN-alpha / IFNA1 / IFN, and purified by antigen affinity chromatography.
-
Clonality
Polyclonal
-
Formulation
0.2 μm filtered solution in PBS
-
Storage instructions
This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free.
Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles. -
Applications
WB: 5-20 μg/ml
-
Validations
Human IFN-alpha / IFNA1 / IFN Western blot (WB) 15408
-
Background
IFNA1, also known as IFN-alpha and IFNA, belongs to the alpha/beta interferon family. Interferons(IFNs) are proteins made and released by host cells in response to the presence of pathogens such as viruses, bacteria, parasites or tumor cells. They belong to the large class of glycoproteins known as cytokines. IFNs stimulate the production of two enzymes: a protein kinase and an oligoadenylate synthetase. They allow for communication between cells to trigger the protective defenses of the immune system that eradicate pathogens or tumors. IFNs can activate immune cells, such as natural killer cells and macrophages; they increase recognition of infection or tumor cells by up-regulating antigen presentation to T lymphocytes; and they also increase the ability of uninfected host cells to resist new infection by virus.Leukocyte interferon is produced predominantly by B lymphocytes. Immune interferon is produced by mitogen- or antigen-stimulated T lymphocytes. IFNA1 is produced by macrophages and has antiviral activities.Immune Checkpoint Immunotherapy Cancer Immunotherapy Targeted Therapy
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"